Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coolibar is a specialized healthcare apparel company focused on the design and commercialization of sun-protective clothing and accessories. It was the first clothing company to receive the Skin Cancer Foundation’s Seal of Recommendation, establishing itself as a leader in the UPF 50+ apparel market. The company's products are engineered to block 98% of UVA and UVB radiation, serving as a critical non-pharmacological intervention for skin cancer prevention and the management of sun-sensitive medical conditions like lupus. Coolibar operates primarily through direct-to-consumer channels and is frequently recommended by dermatologists and oncology professionals worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coolibar.